Print Page | Contact Us | Sign In | Join ASFA
2020 Webinar Schedule

 2020 Webinars Schedule

American Society for Apheresis (ASFA) is pleased to announce that participation in the 2020 webinar series is FREE for all ASFA members! There is a $75 registration fee per webinar for non-members.

If you are interested in leading a future ASFA topical webinar or nursing case study webinar, please reach out to ASFA Head Office.

New: Please note that you also need to register with GoToWebinar in order to receive IP specific login details!

  

 

January 

 

Title: Blood Primes and the Pediatric Patient
Date: Wednesday, January 15, 2020 
Time: 12:00pm - 1:00pm ET
Speaker: Mary Sanders BSN, RN CPN 

Mary Sanders BSN, RN CPN received her nursing degree from the University of Colorado. She began working at Children’s Hospital Colorado (CHCO) in 2005. Mary started working in the Therapeutic Apheresis Department of Children’s Hospital Colorado in 2011 and is currently a Clinical Nurse IV. Mary is a past chair for the Clinical Nurse Practice Council at CHCO.  She received a Daisy Award in 2018. Mary has presented at the Annual O’Neil Pediatric Clinical Update Conference and ASFA Annual meeting on a variety of Apheresis topics.

Learning Objectives: 

  1. Review when blood primes are indicated, and the unique challenges presented in the pediatric patient.
  2. Two case studies - Custom Primes for TPE and ECP with a Modified Blood Prime 

 

 Registration has closed

Members can watch 
the recording in 
ASFA Access

February

 

Title: Blood Donations Screening for Babesia: Past and Future
Date: Wednesday, February 12, 2020 
Time: 12:00pm - 1:00pm ET
Speaker: Laura Tonnetti, MS, PhD

Dr. Laura Tonnetti is a Scientist at the American Red Cross (ARC), where she leads studies related to transfusion-transmissible infectious agents. Her primary focus is on tick-transmitted infections and parasites. Dr. Tonnetti received a M.S. in Biology and a Ph.D. in Experimental Medicine from the University of Perugia in Italy. She worked at the National Institutes of Health before moving to the ARC and becoming involved in the early stages of Babesia blood testing. Dr. Tonnetti has published many articles on the topic, including the ARC’s six-year Babesia microti blood donation screening experience, and a description of transfusion-transmitted babesiosis cases investigated by the ARC between 2010 and 2017.

Learning Objectives: 

  1. Provide a background on transfusion-transmitted babesiosis.
  2. Describe babesia screening performed under investigational protocols.
  3. Discuss the requirements and challenges of implementing babesia screening as recommended in the May 2019 FDA guidance.

Registration has closed

Members can watch 
the recording in 
ASFA Access

 

March

 

Title: LDL Apheresis as a Treatment of FSGS
Date: Wednesday, March 25, 2020 
Time: 12:00pm - 1:00pm ET
Speaker: Joshua J. Zaritsky MD, PhD 

Joshua J. Zaritsky MD, PhD is Chief of the Division of Nephrology at the Nemours/Alfred I. duPont Hospital for Children. He is a graduate of Stanford School of Medicine. Dr. Zaritsky completed his residency in pediatrics at Denver Children’s Hospital and completed a fellowship in pediatric nephrology at Mattel Children’s Hospital at UCLA.  He is board-certified in both Pediatrics and Pediatric Nephrology. He has lectured and published extensively in the fields of chronic kidney disease, iron metabolism and metabolic bone disease.  He is active in several national and international pediatric nephrology research collaboratives. His special interests include acid-base and electrolyte abnormalities, acute kidney injury, dialysis, and renal transplantation.

Learning objectives:

  1. Describe our current understanding of the diagnosis and treatment of pediatric FSGS
  2. Review the current data and protocols using liposorber to treat primary FSGS
  3. Review the current data and protocols using liposorber to treat recurrent FSGS

 

©2019 American Society for Apheresis (ASFA). All rights reserved.
American Society for Apheresis and the ASFA logo are registered service marks.